Acquiring Company
Lilly
Acquired Company
Ajax Therapeutics, Inc.
New YorkBiotechnologyHealth CareOtherBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Lilly has announced its acquisition of Ajax Therapeutics to enhance treatment options for patients suffering from myelofibrosis and polycythemia vera. This strategic move aims to leverage Ajax's innovations and broaden Lilly's portfolio in hematology. The acquisition underscores Lilly's commitment to addressing critical healthcare needs.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- Aurinia acquires Kezar Life Sciences for $6.955/share (March 30, 2026)
- Selecta Biosciences merges with Cartesian Therapeutics (May 17, 2026)
- ESTEVE acquires TerSera's Infusion Business Unit (May 4, 2026)
- Eli Lilly to acquire Ajax Therapeutics for $2.3B, $2.3B (April 27, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
Who to call at Lilly, and when
When Lilly changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lilly raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lilly, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lilly. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lilly makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Ajax Therapeutics, Inc.?
Ajax Therapeutics, Inc. was acquired by Lilly. The deal was reported on April 27, 2026. Lilly unites caring with discovery to create medicines that make life better for people around the world. Lilly is privately held and operates in Biotechnology.
When did Lilly acquire Ajax Therapeutics, Inc.?
Lilly's acquisition of Ajax Therapeutics, Inc. was reported on April 27, 2026. Lilly has announced its acquisition of Ajax Therapeutics to enhance treatment options for patients suffering from myelofibrosis and polycythemia vera. This strategic move aims to leverage Ajax's innovations and broaden Lilly's portfolio in hematology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ajax Therapeutics, Inc. do?
Ajax Therapeutics, Inc. is pursuing uniquely selective approaches to develop novel next generation therapies for myeloproliferative neoplasms (MPNs), including myelofibrosis. It is privately held, operating in Other, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.